IL17A and asthma: PTX3<sup>-/-</sup> mice also exhibited significantly higher AHR parameters.<h4>Conclusions</h4>PTX3 absence enhances neutrophilic inflammation, IL-17A production, IgE responses, and AHR, highlighting PTX3 as a potential biomarker and therapeutic target in type 2- low asthma.